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The differential interferon responses of two strains of Stat1-
deficient mice do not alter susceptibility to HSV-1 and VSV in
vivo
Sarah Katzenell1, Yufei Chen1, Zachary M. Parker1, and David A. Leib1,*
1Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon,
New Hampshire, 03756
Abstract
Stat1 is a pivotal transcription factor for generation of the interferon (IFN)-dependent antiviral
response. Two Stat1 knockout mouse lines have been previously generated, one deleted the N-
terminal domain (DNTD) and one in the DNA-binding domain (DDBD). These widely-used
strains are assumed interchangeable, and both are highly susceptible to various pathogens. In this
study, primary cells derived from DNTD mice were shown to be significantly more responsive to
IFN, and established an antiviral state with greater efficiency than cells derived from DDBD mice,
following infection with vesicular stomatitis virus and herpes simplex virus type-1. Also, while
mice from both strains succumbed rapidly and equally to virus infection, DDBD mice supported
significantly higher replication in brains and spleens than DNTD mice. Endpoint-type
experimental comparisons of these mouse strains are therefore misleading in failing to indicate
important differences in virus replication and innate response.
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INTRODUCTION
Stat1 is a pivotal component of the signaling pathway for both type I and type II interferons
(IFNβ) (O’Shea et al., 2011; Stark and Darnell, 2012). For type I IFNβ, IFNα and IFNβ
engagement with their cognate receptor leads to phosphorylation of Stat1 and the formation
of a heterotrimeric complex of Stat1, Stat2 and ISGF3 which translocates to the nucleus to
stimulate expression of genes that contain IFN-stimulated response elements or ISREs
(Schindler et al., 2007). Engagement of type II IFN (IFNγ) with its cognate receptor leads to
formation of phosporylated Stat1 homodimers that stimulate expression of genes
downstream of gamma-activated sequence (GAS) motifs (Lew et al., 1989). Collectively,
stimulation of ISRE- and GAS-containing genes leads to initiation of the innate antiviral
response and development of adaptive immunity. In addition to its role in establishing the
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antiviral state (Durbin et al., 1996; Meraz et al., 1996), Stat1 additionally plays a role in
growth arrest and apoptosis (Kumar et al., 1997), and cancer (Chan et al., 2012; Hix et al.,
2013). Most importantly, Stat1 is critical for the control of virus infection in humans
(Boisson-Dupuis et al., 2012).
Two domains that are especially important for the function of Stat1 are the N-terminal
domain (NTD) which is necessary for homo- and hetero-dimerization of the protein
(Vinkemeier et al., 1996), and the DNA-binding domain (DBD) that is required for its
function as a site-specific transcription factor (Schindler et al., 1995). Both of these domains
have been deleted in the context of knockout mouse strains (Durbin et al., 1996; Meraz et
al., 1996) and these two lines have been used extensively in literally hundreds of studies of
signal transduction in innate immunity, innate immunity to bacterial and viral pathogens,
and tumorigenesis (see for example (Bente et al., 2010; Hofer et al., 2012; Khodarev et al.,
2004; Klover et al., 2010). These mouse lines have been used and interpreted more or less
interchangeably since their separate development in 1996, and in their respective initial
characterizations both lines were highly susceptible to vesicular stomatitis virus (VSV)
infection. In 2005, a study using both Stat1-deficiant mouse lines concluded that both lines
were relatively resistant to dengue virus infection relative to IFNαβγR−/− mice (Shresta et
al., 2005). That study reported that mice lacking the NTD were capable of making IFNα in
response to virus infection and concluded that Stat1-independent mechanisms were
responsible. A subsequent study showed that while both Stat1-deficient mice were very
susceptible to lethal infection, HSV-1 was neurotropic in the NTD-deficient line (DNTD),
but viscerotropic in the DBD-deficient line (DDBD), with significant involvement of the
liver (Pasieka et al., 2011). This and another study has led to the suggestion that the DNTD
may have a small amount of residual Stat1-activity (Bowick et al., 2012). An important
caveat of the previous HSV study, however, was that HSV is resistant to IFN, encoding
multiple genes that inhibit IFN responses and Stat1 signaling (for example ICP0, ICP34.5
and vhs (Halford et al., 2006; Leib et al., 2000; Pasieka et al., 2008). This complicates the
overall interpretation of the data with HSV since these genes may function with differential
efficacy against residual Stat1 activity. Moreover, the direct comparison of DNTD and
DDBD mice was limited to a bioluminescence imaging analysis of increased viral hepato-
tropism in DDBD mice, with no analyses of IFN responses, comparative replication, or
mortality performed.
In the present study, we therefore directly compared the replication of HSV in parallel with
VSV, an IFN-sensitive virus, in primary fibroblasts derived from DNTD and DDBD mice.
This approach also allows us to directly compare the susceptibility of DNTD and DDBD
mice to both RNA and DNA viruses. We examined the response of these fibroblasts to IFN
and also assessed HSV and VSV pathogenesis in both mouse strains. Our study revealed that
despite significant differences in the abilities of DNTD and DDBD fibroblasts to respond to
IFN and control VSV and HSV replication in vitro, and clear differences in viral replication
in vivo, both strains of mice are highly and equally susceptible to VSV and HSV as judged
by endpoint analyses. These data show that despite the ability of primary cells derived from
DNTD mice to respond to IFN and partially control virus replication, these partial IFN
responses are insufficient to substantially alter VSV- and HSV-induced mortality. The
comparability of these two Stat1-deficient strains is therefore dependent upon experimental
system and virus, and future and previous virological data from these two mouse strains
must be carefully interpreted and compared.
Katzenell et al. Page 2
Virology. Author manuscript; available in PMC 2015 February 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
RESULTS
VSV and HSV-1 replicate with significantly reduced efficiency in IFN-treated primary MEFs
derived from DNTD relative to DDBD mice
Monolayers of primary MEFs derived from control, DNTD and DDBD mice were treated
overnight with varying doses of IFNβ, and subsequently infected with VSV at an MOI 0.1,
and monolayers harvested and titered at 12 hours post-infection (Fig. 1A). In the absence of
IFN treatment, all three lines yielded equivalent levels of VSV at 12 hours, suggesting that
at this timepoint endogenous IFN synthesis was insufficient to control VSV. Pre-treatment
with as little as 0.02units/ml of IFNβ, however, led to a >50-fold (p<0.05) lower yield of
VSV from control and DNTD relative to DDBD MEFs. Yields from control MEFs
decreased significantly in a dose-dependent fashion as IFN levels were increased, reaching a
nadir at 0.2U/ml. Yields from DNTD MEFs were not changed significantly with increasing
IFN treatment until a concentration of 10 U/ml was used, resulting in a >1,000-fold
reduction in VSV titers (p<0.0001) relative to untreated MEFs. In contrast, yields from
DDBD MEFs were not changed with increasing IFN treatment up to 1U/ml, with a non-
statistically significant 8-fold reduction in titer at 10 U/ml of IFNβ. Notably the control of
VSV replication did not alter further in DDBD MEFs even at a higher concentration of
100U/ml (data not shown). Taken together, these data demonstrate that DDBD and DNTD
MEFs differ significantly from each other (p<0.0001) in their abilities to control VSV
replication in response to IFN treatment, with DNTD MEFs being more responsive to IFN
than DDBD. As expected, both Stat1−/− strains were significantly less responsive to IFN
than control MEFs. The rank order of these MEFs to respond to IFN and control VSV
replication, (control ≫ DNTD > DDBD) was recapitulated when infected with HSV-1
strain KOS (Fig. 1B). Together, these data largely dispel the hypothesis that it is the
differential capability of HSV-1 to counter any residual activity of the DNTD and DDBD
Stat1 alleles that results in disparate viral growth in these two mouse strains. Rather, these
data support the notion that it is simply the intrinsic differential ability of these two mouse
lines to respond to IFN that results in unequal control of virus replication.
IFN-treated primary MEFs derived from DNTD relative to DDBD mice differentially up-
regulate IFIT1
To further address the hypothesis that DNTD and DDBD mice differ in their ability to
respond to IFN, we measured ISG gene expression in response to IFN treatment in the
absence of viral infection. We used IFIT1 as a representative ISG since it is strongly up-
regulated by IFN in a Stat1-dependent fashion (Bluyssen et al., 1994). At all concentrations
of IFN used, MEFs derived from 129SVEV mice responded strongly (Fig. 1C). Indeed,
addition of 1U/ml of IFNβ appeared sufficient to saturate the induction of IFIT1. In contrast,
the addition of IFN induced a dose-dependent increase in IFIT1 expression from MEFs
derived from both DNTD and DDBD mice. Interestingly, and in concordance with the VSV
and HSV growth data (Figs 1A and 1B), induction of IFIT1 was higher in the DNTD MEFs
relative to DDBD. Furthermore, despite an overall lower trend, the induction of IFIT1 RNA
in DNTD MEFs was statistically indistinguishable from 129SVEV following treatment with
10 and 100 U/ml IFNβ. Together, these data show that primary cells derived from DNTD
and DDBD mice differ significantly at the level of control of virus replication and ISG
induction.
DNTD and DDBD mice exhibit equivalent susceptibility to VSV
The results above showing differential replication of VSV and HSV-1 in DNTD and DDBD
MEFs led us to speculate whether the rank order of resistance (control ≫ DNTD > DDBD)
would recapitulate in vivo. The original publications describing DNTD and DDBD mice
showed high mortality following VSV infection for both strains compared to controls
Katzenell et al. Page 3
Virology. Author manuscript; available in PMC 2015 February 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
(Durbin et al., 1996; Meraz et al., 1996), but no direct or quantitative comparisons of the
Stat1−/− mouse strains were performed. Several studies have shown that DNTD mice are
also highly susceptible to HSV-1, but direct comparison to DDBD mice has been limited to
a single study of hepatotropism (Pasieka et al., 2011). We therefore wished to compare these
mice in more detail following infection with VSV and HSV-1. We infected mice ip with
100pfu VSV and measured time for mice to reach to endpoint criteria, as well as assessing
titers in liver and brain on day 2, one day before the onset of mortality (Fig. 2). There were
significantly higher VSV titers in both the brains and livers of DDBD relative to DNTD and
control mice (p<0.001), consistent with the in vitro data shown above (Fig 2A). Based on
these replication data, we anticipated that the DDBD mice would be more susceptible to
VSV-induced mortality than DNTD mice. Surprisingly, following ip infection with VSV
there was rapid and synchronous mortality observed in both DNTD and DDBD mice at 3
days post-infection, while the wild-type mice all survived out to the 21 day cutoff time point
(Fig. 2B). Given this early simultaneous VSV-induced mortality we postulated that the 100
pfu inoculum might be too high to parse differences between the mouse strains. We
therefore infected mice ip with a lowered dose of 20 pfu VSV and again examined mortality
(Fig. 2C). At this lower dose we observed a more step-wise pattern of mortality, with
survival of a total of 11/34 (32%) DDBD mice, and 3/19 (16%) DNTD mice, with 7/7
(100%) of control mice surviving. While Kaplan-Meier plots for both DNTD and DDBD
mice were significantly different (p>0.0001) from control mice, they were not significantly
different from each other. That stated, there was a non-significant trend for DNTD to be
more susceptible to VSV infection relative to DDBD mice. This slight change in
susceptibility notwithstanding, these results were surprising given the significantly greater
replication of VSV in DDBD MEFs relative to DNTD, and the higher titers in the livers and
brains of DDBD relative to DNTD mice. To examine this further we infected mice with 2 ×
106 pfu/eye of KOS and monitored time to reach endpoint criteria (Fig. 2D). Similar to the
experiments using VSV, there was no discernable difference between DDBD and DNTD
mice in their mortality following infection with HSV-1. This further extends the idea that
these mice are equivalent in terms of general susceptibility to infection, regardless of the
IFN sensitivity of the pathogen, and despite demonstrable significant differences in the
responses of primary cells to IFN.
DISCUSSION
The data of this study underscore the complexity of interpretation of data from knockout
mouse models in general, and also further give caution to making direct comparisons
between these two Stat1−/− mouse strains. The in vitro data described herein demonstrate
that MEFs derived from DDBD and DNTD mice respond differentially to IFN in terms of
their ability to control VSV, and HSV-1 -- two very different viruses, especially with regard
to their IFN sensitivities. HSV-1 encodes for several specific functions that interfere directly
with Stat1 and the antiviral activities of IFN, and is generally resistant to IFN (Mossman and
Ashkar, 2005). While VSV does antagonize the type I IFN response through blocking RNA
export via the matrix protein (Waibler et al., 2007), VSV remains highly susceptible to the
effects of IFN. Despite their differences in IFN sensitivity, both viruses replicate with a
similar pattern in DDBD and DNTD MEFs in the presence of IFN. Importantly, this
demonstrates that it is an inherent difference in the ability of these Stat-deficient cells to
mount an antiviral response, rather than a difference in the ability of these viruses to counter
any residual functions of DDBD and DNTD alleles. This conclusion is further supported by
the observation that the induction of IFIT1 RNA synthesis by IFNβ treatment in the absence
of virus infection, clearly differs between primary cells derived from the 2 mouse strains.
Previous work eliminated the possibility that mouse background account for the phenotypic
disparity (Pasieka et al., 2011), so these data thereby show formally that primary cells
derived from these mouse lines differ in their molecular and functional antiviral responses.
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One additional caveat is that only fibroblasts were examined, and it is possible that IFN-
driven responses in DDBD and DNTD mice may also differ by cell type. The responses of
each cell type must therefore be determined empirically.
The relative equivalence in susceptibility to VSV of DDBD and DNTD mice was surprising
given the differences in VSV production between the two mouse lines. This pattern of
equivalent lethality but non-equivalent viral replication, however, is not exclusive to VSV,
since HSV-1 also induced similar mortality in these two mouse strains despite the disparate
replication patterns in vitro shown in this study, and in vivo (Pasieka et al., 2011). These
data suggest that the susceptibility of both strains to viral infection is sufficiently high such
that even relatively large differences in viral titers in critical organs (such as liver and brain)
do not significantly alter the timing with which these mice reach endpoint clinical criteria. It
is likely that once the innate immune response is compromised below a certain functional
threshold (as in DNTD), further compromise (as in DDBD) does not result in further
detectable susceptibility as judged by endpoint analysis following a pathogenic challenge.
This is consistent with data showing that VSV kills 100% of Ifit2−/− mice within 6 days
following intra-nasal infection of VSV regardless of input dose (Fensterl et al., 2012). That
study also showed that mortality and viral titers were often not correlated for VSV. This also
emphasizes the relative crudeness of endpoint-type experiments, which although
informative, do not reveal underlying important differences in biology, tropism and
pathogenesis. Another confounding issue is route of infection, which likely also plays a
critical role in the relative susceptibilities of these mouse strains.
These Stat1-deficient mouse lines created by Meraz et al., and Durbin et al. (Durbin et al.,
1996; Meraz et al., 1996) have been used in a wide variety of in vitro and in vivo studies,
with almost 600 citations of these original papers in the primary literature. The data of this
study show that for in vitro experiments at least, data acquired from these two lines cannot
be directly compared. In addition, Stat1-independent effects should be equivalent in both
lines, so the data further support the idea that the Stat1 mutation in DDBD mice represents a
more complete ablation of Stat1 function than mutation in the DNTD strain. The DDBD
strain, therefore seems preferable for studies in which it is necessary for the mice to lack any
residual Stat1 activity which may confound interpretation of the data. The DNTD strain,
however, is a closer model of human Stat1 insufficiency, since, humans deficient in Stat1
and DNTD mice both succumb to HSV-1 encephalitis (Boisson-Dupuis et al., 2012; Pasieka
et al., 2009), whereas DDBD mice acquire fulminant hepatitis (Pasieka et al., 2011). Clearly
both mouse strains have strengths and weaknesses for investigation of IFN-driven innate
immunity to viruses, but it is apparent that these mouse strains differ significantly in terms
of their innate responses, regardless of virus type and IFN sensitivity.
METHODS AND MATERIALS
Cells, viruses, and animal infection procedures
Mouse embryo fibroblast (MEF) cultures were generated from 129 Sv/Ev, and Stat1−/− mice
at embryonic day 15 and passaged once before being plated for infection. MEFs were
cultured in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal calf serum,
0.1 mM sodium pyruvate, 250 U/ml penicillin, 250 μg/ml streptomycin, and 250 ng/ml
amphotericin B. Isogenic MEFs were also utilized. For multiple-step growth curves, cells
were pretreated overnight with the appropriate concentration of IFN (Sigma, St. Louis, MO),
and cells were infected at a multiplicity of infection (MOI) of 0.01. All titering and viral
stock preparation was performed on Vero cells as previously described. The VSV used was
strain Indiana, and the HSV-1 strain was KOS. Mouse strains used included the control
129S6 as wild type mice (Taconic Farms, Germantown, NY), 129S6 Stat1-deficient mice
lacking the N-terminal domain (referred to here as DNTD or Stat1−/−NTD), and 129 Stat1-
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deficient mice lacking the DNA binding domain (referred to here as DDBD or
Stat1−/−DBD). Mice were genotyped by PCR and housed in the barrier facility in the Center
for Comparative Medicine and Research at The Geisel School of Medicine at Dartmouth and
were infected intraperitoneally or corneally in the biohazard facility between the ages of 6–8
weeks (Rader et al., 1993; Strelow and Leib, 1995). Mice were harvested at appropriate
times and organs dissected and titered as previously described, and times to reaching of
endpoint criteria recorded. Sentinel mice were screened every 3 months and determined to
be negative for adventitious mouse pathogens, in particular mouse norovirus. Mice were
housed, infected, and euthanized when necessary in accordance with all Federal and
University policies.
Quantitative real-time PCR
MEFs from the three mouse strains were cultured as above and were treated with IFNβ (0, 1,
10 or 100 U/ml) for 6 hours, then RNA was collected using the RNeasy kit (Quiagen). The
RNA was treated with DNase (New England Biolabs, MA), and cDNA was synthesized
using the SuperScript III kit (Life Technologies) with random hexamers (Promega, WI). For
QPCR, SYBR Green (Life Technologies, NY) was used with primers for IFIT1 (Fw: TGC
TTT GCG AAG GCT CTG AAA GTG, Rv: TGG ATT TAA CCG GAC AGC CTT CCT,
200nM) and GAPDH (GAPDH Fw: CAT CTT CCA GGA GCG AGA TCC C Rv: CAA
ATG AGC CCC AGC CTT CTC C 400nM). IFIT1 values were calculated by the 2−DDCT
method (Livak and Schmittgen, 2001) normalized to GAPDH, and values for IFNβ-treated
MEFs were normalized to untreated MEFs of the same strain.
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We compared 2 strains of Stat1---deficient mice by infection with VSV and
HSV---1.
Significant differences in antiviral activity and ISG induction were seen in vitro.
Significant differences in virus replication were observed in vivo.
The susceptibilities of these mice to lethal infection are comparable.
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FIGURE 1.
A. Titers of VSV 12 hours postinfection from MEFs infected at MOI 0.01. MEFs (derived
from control 129 mice, or DDBD and DNTD Stat1-deficient mice) were pre-treated for 18
hours with varying concentrations of IFNβ. B. Titers of HSV-1 24 hours postinfection from
MEFs infected at MOI 0.01 pretreated for 18 hours with varying concentrations of IFNβ. C.
Real-time PCR analysis using the 2−DDCT method for IFIT1 transcript 6 hours post-
treatment with indicated amounts of IFNβ. Data shown for each panel are derived from two
or more independent experiments performed in duplicate. Dashed lines indicate the limit of
detection, * indicates statistically significantly different from untreated controls (p<0.05,
≥0.0001), § indicates statistically significantly different from wild-type cells (p<0.05,
≥0.004). Data shown in panels A and B are averaged from a minimum of 2 experiments
performed in duplicate, or in panel C in triplicate.
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FIGURE 2.
Replication and lethality of VSV and HSV in DDBD and DNTD mice. A. VSV titers in
brain and liver of control (129), DDBD and DNTD mice 2 days post ip infection with
100pfu of VSV. Data were collected from a total of 42 mice over 2 experiments with a
minimum of 5 mice per group. B. Time taken to reach endpoint mortality criteria for control
(129), DDBD and DNTD mice following ip infection with 100pfu VSV. Data were collected
from a total of 16 mice (n=7 for control, n=5 for DDBD and n=6 for DNTD). C. Time taken
to reach endpoint mortality criteria for control (129), DDBD and DNTD mice following ip
infection with 20pfu VSV. Data were collected from a total of 16 mice (n=7 for control,
n=34 for DDBD, n=19 for DNTD). NS = not statistically significant. D. Time taken to reach
endpoint mortality criteria for control (129), DDBD and DNTD mice following corneal
infection with 2 × 106 pfu/eye. Data were collected from a total of 23 mice (n=9 for control,
n=7 for DDBD, n=7 for DNTD).
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